Growth differentiation factor 15 (GDF-15) plasma levels increase during bleomycin- and cisplatin-based treatment of testicular cancer patients and relate to endothelial damage.
INTRODUCTION:Chemotherapy-related endothelial damage contributes to the early development of cardiovascular morbidity in testicular cancer patients. We aimed to identify relevant mechanisms of and search for candidate biomarkers for this endothelial damage. METHODS:Human micro-vascular endothelial c...
Main Authors: | Renske Altena, Rudolf S N Fehrmann, Hink Boer, Elisabeth G E de Vries, Coby Meijer, Jourik A Gietema |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4295859?pdf=render |
Similar Items
-
GDF15 and Growth Control
by: Paul J. Emmerson, et al.
Published: (2018-11-01) -
CRP Stimulates GDF15 Expression in Endothelial Cells through p53
by: Yoonseo Kim, et al.
Published: (2018-01-01) -
Cisplatin and bleomycin-induced acute peripheral-vascular stenosis in patient with testicular cancer
by: Tayyar Alp Ozkan, et al.
Published: (2016-01-01) -
GDF15 secreted by senescent endothelial cells improves vascular progenitor cell functions.
by: Guillaume Ha, et al.
Published: (2019-01-01) -
Growth differentiation factor-15 (GDF-15) for cardiovascular risk assessment
by: Wiesław Piechota, et al.
Published: (2018-03-01)